Anti-LYVE1 antibody
| Name | Anti-LYVE1 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab36993 |
| Prices | $390.00 |
| Sizes | 50 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | WB IHC-P IHC-F FC |
| Species Reactivities | Dog, Human |
| Antigen | Recombinant fragment corresponding to Human LYVE1 aa 24-232 |
| Description | Rabbit Polyclonal |
| Gene | LYVE1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
IHC with paraffin-embedded sections of human intestine (border area of a colon carcinoma) using antibody ab36993.
The staining was performed on frozen sections from human colon carcinoma using ab36993 (polyclonal anti-human LYVE-1 antibody; protein-A purified; 10 µg/ml).
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of lymphatic vessels of malignant canine mammary tumor tissue sections labelling LYVE1 with ab36993.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of lymphatic vessels of benign canine mammary tumor tissue sections labelling LYVE1 with ab36993.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of lymphatic vessels of normal canine mammary tissue sections labelling LYVE1 with ab36993.
All lanes : Anti-LYVE1 antibody (ab36993)Lane 1 : Human LYVE1 protein fragment (ab54341)Lane 2 : Mouse LYVE1 protein fragment (ab54342)
Flow Cytometry analysis of human dermal microvascular endothelial cells (HDMVEC) labelling LYVE1 with ab36993.
Product References
Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis - Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis
Davis JM, Hyjek E, Husain AN, Shen L, Jones J, Schuger LA. J Histochem Cytochem. 2013 Aug;61(8):580-90.
Lymphatic and nerve distribution throughout the parametrium. - Lymphatic and nerve distribution throughout the parametrium.
Bonneau C, Cortez A, Lis R, Mirshahi M, Fauconnier A, Ballester M, Darai E, Touboul C. Gynecol Oncol. 2013 Dec;131(3):708-13.
CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of - CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of
Teijeira A, Palazon A, Garasa S, Marre D, Auba C, Rogel A, Murillo O, Martinez-Forero I, Lang F, Melero I, Rouzaut A. FASEB J. 2012 Aug;26(8):3380-92.
Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes - Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes
Cueni LN, Chen L, Zhang H, Marino D, Huggenberger R, Alitalo A, Bianchi R, Detmar M. Blood. 2010 Nov 18;116(20):4376-84.
Clinical implications of increased lymph vessel density in the lymphatic - Clinical implications of increased lymph vessel density in the lymphatic
Zhang SQ, Yu H, Zhang LL. BMC Cancer. 2009 Feb 21;9:64.
The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage - The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage
Yu H, Zhang S, Zhang R, Zhang L. J Exp Clin Cancer Res. 2009 Jul 9;28:98.